Loading...
Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis
BACKGROUND: This case is the first report describing rapid, successful treatment of severe atopic dermatitis (AD) and comorbid type-2 inflammatory diseases in the same patient, with dupilumab treatment, with no side-effects. CASE PRESENTATION: We report on effects of dupilumab in a patient with seve...
Na minha lista:
| Udgivet i: | Clin Mol Allergy |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8207639/ https://ncbi.nlm.nih.gov/pubmed/34134707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-021-00144-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|